Search for: "Boehringer Ingelheim Pharma GMBH & Co. KG"
Results 1 - 17
of 17
Sorted by Relevance
|
Sort by Date
9 Aug 2009, 4:54 pm
Boehringer Ingelheim Pharma GmbH & Co. [read post]
8 May 2016, 9:59 pm
Boehringer Ingelheim Pharma GmbH & Co. [read post]
2 Jun 2018, 5:55 am
A full summary of this case has been published on Kluwer IP Law More from our authors: Mediation: Creating Value in International Intellectual Property Disputes by Théophile Margellos, Sophia Bonne, Gordon Humphreys, Sven Stürmann € The post United Kingdom: Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, Court of Appeal of England and Wales,… [read post]
24 Feb 2017, 1:31 am
€ 160 The post United Kingdom: Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, Court of Appeal of England and Wales, Civil Division, A3 2016 0271, 16 December 2016 appeared first on Kluwer Patent Blog. [read post]
9 Jul 2018, 10:00 pm
More from our authors: Mediation: Creating Value in International Intellectual Property Disputes by Théophile Margellos, Sophia Bonne, Gordon Humphreys, Sven Stürmann € The post Ireland: Re Boehringer Ingelheim Pharma GmbH & Co. [read post]
15 Jul 2007, 6:11 pm
Boehringer Ingelheim Pharma GmbH Co. [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
21 Dec 2016, 12:48 am
These are the issues considered by the Court of Appeal in last week's decision concerning an application for permission to appeal in Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG [2016] EWCA Civ 1296. [read post]
12 Mar 2015, 11:09 am
Today's the day that many pharmaceutical patent term extension-watchers have been waiting for with feelings of optimism or anxiety: the day on which the Court of Justice of the European Union (CJEU) delivered its ruling in Case C‑577/13, Actavis Group PTC EHF, Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. [read post]
30 Dec 2009, 3:44 am
In this event Panels partially dismiss complaints to the extent that they include additional unrelated respondents, as in Boehringer Ingelheim Pharma GmbH & Co. [read post]
16 Mar 2015, 3:10 am
CJEU rules in telmisartan SPC disputeAfter his own earlier post on the CJEU’s decision in Case C‑577/13, Actavis Group PTC EHF, Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. [read post]
1 Dec 2009, 9:45 am
Intervet Inc. and Boehringer Ingelheim Vetmedica, Inc. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
26 Apr 2007, 9:28 am
The two big trade mark decisions of the European Court of Justice today have been a little overshadowed by the festivities for World Intellectual Property Day, but the IPKat took just enough time off from his ecstatic celebrations to check the Curia website and see what the ECJ had in store for him.Right: objection to the repackaging of pharma products has led to some grey goods traders taking extreme measures to avoid trade mark infringment litigationCase C-348/04, Boehringer… [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics… [read post]
4 May 2017, 1:00 am
Relevant Judicial Practice Boehringer Ingelheim Pharma GmbH & Co KG v. [read post]
